These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24911491)

  • 1. The nature of Asian biopharmaceutical innovation.
    Friedman Y
    Nat Biotechnol; 2014 Jun; 32(6):523-4. PubMed ID: 24911491
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of patent innovation in the field of brachytherapy.
    Miljanic M; Prabhu AV; Patel M; Lewis GD; Kim T
    Brachytherapy; 2020; 19(4):510-517. PubMed ID: 32249181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rise and fall of innovation in biofuels.
    Albers SC; Berklund AM; Graff GD
    Nat Biotechnol; 2016 Aug; 34(8):814-21. PubMed ID: 27504772
    [No Abstract]   [Full Text] [Related]  

  • 4. Guest editors' note: Special issue associated with the 2013 ASA Biopharmaceutical FDA/Industry Statistics Workshop.
    Binkowitz B; Yue LQ
    J Biopharm Stat; 2014; 24(5):965-7. PubMed ID: 25014118
    [No Abstract]   [Full Text] [Related]  

  • 5. Enabling policy planning and innovation management through patent information and co-authorship network analyses: a study of tuberculosis in Brazil.
    Vasconcellos AG; Morel CM
    PLoS One; 2012; 7(10):e45569. PubMed ID: 23056208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopharmaceutical benchmarks--2003.
    Walsh G
    Nat Biotechnol; 2003 Aug; 21(8):865-70. PubMed ID: 12894198
    [No Abstract]   [Full Text] [Related]  

  • 7. American export control, technology spillover and innovation of Chinese pharmaceutical Industry.
    Hui J
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1151-1155. PubMed ID: 28671099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patents as proxies: NIH hubs of innovation.
    Kalutkiewicz MJ; Ehman RL
    Nat Biotechnol; 2014 Jun; 32(6):536-7. PubMed ID: 24911494
    [No Abstract]   [Full Text] [Related]  

  • 9. Start-ups: A sense of enterprise.
    Savage N
    Nature; 2016 May; 533(7601):S10-2. PubMed ID: 27144602
    [No Abstract]   [Full Text] [Related]  

  • 10. The publishing and patenting strategies of successful university spinoffs in the biopharmaceutical industry.
    Erden Z
    Drug Discov Today; 2017 Jan; 22(1):5-9. PubMed ID: 27634342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The performance of China's biomedical innovation: a scientometric analysis.
    Tang X; Du J
    Sci China Life Sci; 2016 Oct; 59(10):1074-1082. PubMed ID: 27437700
    [No Abstract]   [Full Text] [Related]  

  • 12. Top 20 translational researchers of 2014.
    Huggett B; Paisner K
    Nat Biotechnol; 2015 Sep; 33(9):897. PubMed ID: 26349903
    [No Abstract]   [Full Text] [Related]  

  • 13. Start-up model patently flawed.
    Corbyn Z
    Nature; 2010 Jul; 466(7304):303. PubMed ID: 20631768
    [No Abstract]   [Full Text] [Related]  

  • 14. Not quite a myriad of gene patents.
    Graff GD; Phillips D; Lei Z; Oh S; Nottenburg C; Pardey PG
    Nat Biotechnol; 2013 May; 31(5):404-10. PubMed ID: 23657391
    [No Abstract]   [Full Text] [Related]  

  • 15. Patent drop reveals pressures on industry.
    Lawrence S
    Nat Biotechnol; 2004 Aug; 22(8):930-1. PubMed ID: 15286630
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotech patenting slows in 2004.
    Lawrence S
    Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
    [No Abstract]   [Full Text] [Related]  

  • 17. Is the United States still dominant in the global pharmaceutical innovation network?
    Hu Y; Scherngell T; Man SN; Wang Y
    PLoS One; 2013; 8(11):e77247. PubMed ID: 24223710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative overview of innovation and patent filings in Radiopharmacy.
    Miranda ACC; Lobato DR; Araújo EB
    Einstein (Sao Paulo); 2020; 18():eGS4816. PubMed ID: 31778463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent patent applications in drug screening.
    Nat Biotechnol; 2007 Aug; 25(8):869. PubMed ID: 17687360
    [No Abstract]   [Full Text] [Related]  

  • 20. First-to-patent does not predict first- or best-in-class: analysis of approved small molecule vs. biologic drugs.
    Roland GE; Xu JJ; Wagner JA
    Clin Pharmacol Ther; 2015 Jan; 97(1):19-21. PubMed ID: 25670379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.